{
    "2020-04-01": [
        [
            {
                "time": "",
                "original_text": "药明生物涨近4% 控股股东配售部分股权",
                "features": {
                    "keywords": [
                        "药明生物",
                        "涨近4%",
                        "控股股东",
                        "配售",
                        "部分股权"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【光大医药|年报点评】上海医药：工商持续稳健增长，逐步迎来创新升级",
                "features": {
                    "keywords": [
                        "光大医药",
                        "年报点评",
                        "上海医药",
                        "工商持续稳健增长",
                        "创新升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}